Jonathan Finn's most recent trade in Atossa Therapeutics Inc was a trade of 125,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atossa Therapeutics Inc | Jonathan F. Finn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Jonathan F. Finn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Jonathan Finn | Director | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 10 Apr 2024 | 25,000 | 25,000 (0%) | 0% | 1.8 | 44,250 | Common Stock |